Charlotte Robinson

DocwireNews

Evergreen Nephrology announced that it has raised $130 million in capital to expand its value-based care model for kidney disease. The funding came from Rubicon Founders, Oak HC/FT, a group of existing investors, and K2 HealthVentures.
The funding will help Evergreen expand into new regions and implement advanced technologies to help improve clinical outcomes, streamline delivery of care, and lessen the administrative burden on nephrologists.
Evergreen offers nephrologist partners wraparound support through analytical insight and tools and a dedicated patient care team including nurse care managers, care coordinators, social workers, dietitians, and pharmacists. The goal is to ensure holistic and personalized patient care while allowing nephrologists to focus on their clinical expertise and leadership in kidney disease management.
Source: <a href="https://www.prnewswire.com/news-releases/evergreen-nephrology-raises-130-million-to-transform-and-expand-access-to-value-based-kidney-care-302344770.html" target="_blank" rel="noopener">Press release</a>

Richard S. Finn, MD

Adam Yopp, MD

Does Adjuvant Therapy Benefit High-Risk Liver Cancer Patients? Insights from IMbrave050

Liver Cancer

Emily Menendez

Gemcitabine and Cisplatin +/- Nab-Paclitaxel for Newly Diagnosed BTC: Results From SWOG S1815

Bile Duct Cancer

Rob Dillard

Novel Tool is Effective at Predicting the Onset of Mild Cognitive Impairment and Alzheimer Dementia

Dementia

Latest News

Evergreen Nephrology Plans Expansion With $130 Million in New Capital

Nephrology Times

Evergreen Nephrology has raised $130 million in capital to expand its value-based care model for kidney disease.

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe